Find a Tender
planned
Official procurement procedure
Malaria & Arbovirus detection assays
Blood-testing reagents
Diagnostic kits
Diagnostic supplies
+1 more
Published value
£1
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Blood and Transplant: "Malaria & Arbovirus detection assays". Published status: planned. Published value: £1. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Blood and Transplant | Scope & Categories | Not published | Submission Window | planned No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £1 |
Bidder Intelligence · Authority Profile: NHS Blood and Transplant
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Blood and Transplant. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
2Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 15 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Blood and Transplant | Procedure methodNot published | Procurement categoryNot published |
Statusplanned | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published29 Feb 2024, 11:52 GMT | Last source update29 Feb 2024, 11:52 GMT | Recurring procurementNot published |
ClassificationBlood-testing reagents, Diagnostic kits, Diagnostic supplies, Laboratory services | ||
Delivery area | ||
OCIDocds-h6vhtk-044445 | ||
What is being bought
The Kit Evaluation Group (KEG) assesses the suitability of molecular and serological microbiological assays to be used for the screening of blood and non-blood (e.g. stem cell, tissue) donors to ensure assays are suitable in terms of sensitivity and specificity. KEG approval of suitable assays is a requirement of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).<br/><br/>NHSBT are looking to perform two evaluations, one on malaria detection assays and the other on arbovirus detection assays, which utilise high-throughput automated Nucleic Acid Testing (NAT) technology. This system needs to be integrated (extraction and amplification stages on the same automated equipment) and target DNA or RNA in blood samples collected from blood and non-blood donors. An automated and integrated NAT system is essential to minimise manual steps and to allow for high-throughput testing.<br/><br/>These evaluations are driven by horizon scanning and testing resilience and the proposed work would be standalone evaluations not linked to any procurement exercises. To learn more about KEG we will be holding virtual webinars in the summer of 2024.
What changed
From the official release history
- Published value updated to £1
29 Feb 2024, 11:52 GMT - Status changed to planned
29 Feb 2024, 11:52 GMT - Official notice release published
29 Feb 2024, 11:52 GMT - Buyer information updated
29 Feb 2024, 11:52 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedplannedPublished valueNot publishedThe Kit Evaluation Group (KEG) assesses the suitability of molecular and serological microbiological assays to be used for the screening of blood and non-blood (e.g. stem cell, tissue) donors to ensure assays are suitable in terms of sensitivity and specificity. Kit Evaluation Group (KEG) approval of suitable assays is a requirement of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).<br/><br/>NHSBT are looking to perform two evaluations, one on malaria detection assays and the other on arbovirus detection assays, which utilise high-throughput automated Nucleic Acid Testing (NAT) technology. This system needs to be integrated (extraction and amplification stages on the same automated equipment) and target DNA or RNA in blood samples collected from blood and non-blood donors. An automated and integrated NAT system is essential to minimise manual steps and to allow for high-throughput testing.<br/><br/>These evaluations are driven by horizon scanning and testing resilience and the proposed work would be standalone evaluations not linked to any procurement exercises. To learn more about KEG we will be holding virtual webinars in the summer of 2024. <br/>Please email tennille.madigan@nhsbt.nhs.uk for further information and expressions of interest by 30th April 2024.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
29 Feb 2024, 11:52 GMT
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS Blood and Transplant
Contracting authority GB-FTS-13217Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published